<DOC>
	<DOCNO>NCT00233103</DOCNO>
	<brief_summary>Randomized clinical trial sertraline vs. placebo post-TBI depression</brief_summary>
	<brief_title>Treatment Post-Traumatic Brain Injury ( TBI ) Depression</brief_title>
	<detailed_description>Purpose : The purpose study document efficacy sertraline ( Zoloft ) treatment depression ( major depressive disorder ) TBI , include impact quality life . Researchers also explore effect sertraline anxiety disorder , often accompany post-TBI depression . Background : Major depression experience many people TBI prior injury often people without brain injury . Many study also show high 'normal ' incidence loom many year post TBI . Major depression associate variety negative outcome , include poor function basic activity , reduce employment , elevate divorce rate , reduce social recreational activity increase sexual dysfunction . Need Research : Of current drug treatment major depression , sertraline similar drug ( know selective serotonin reuptake inhibitor , selective serotonin reuptake inhibitor ( SSRIs ) ) side effect people experience brain injury show effective people know brain injury . However , information impact SSRIs post-TBI depression , base randomize , double-blind study , unavailable . Current Research Activity : Approximately 50 men woman volunteer post TBI currently diagnose major depressive disorder randomly assign 12-week period take Zoloft placebo . Over period study , participant severity depressive symptom assess ( well symptoms anxiety ) ; simple measure volunteer 's perceive quality life implement prior study termination . It hypothesize sertraline reduce symptom depression anxiety increase person 's perceive quality life significantly great extent placebo .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>18 year old experience TBI document loss consciousness evidence TBI ( i.e. , evidence pathology neuroimaging ) least 6 month postinjury Englishspeaking residential telephone service live within 1.5 hour New York City able comprehend answer verbal write questionnaire willing provide consent participate 12 week drug study treat Major Depressive Disorder ( MDD ) ; current MDD diagnose use Structured Clinical Interview Diagnostic Statistical Manual Diploma Social Medicine ( DSM ) Disorders ( SCID ) , severity MDD rat least 18 HAMD . currently take antidepressant medication ( include monamine oxidase inhibitor ( MOAs ) tricyclic antidepressant ( TCAs ) unwilling abstain seek new psychosocial pharmacologic treatment course study currently psychotherapy active suicidal plan and/or require hospitalization prior use sertraline currently experience serious medical illness currently pregnant breast feed mass brain lesion neurological diagnosis TBI history current past psychosis mania current substance abuse history clinically significant liver renal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Sertraline</keyword>
	<keyword>TBI</keyword>
	<keyword>depression</keyword>
	<keyword>SSRI</keyword>
	<keyword>brain injury</keyword>
</DOC>